Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Age-related difference in tamoxifen disposition

F Peyrade1, M Frenay, M C Etienne

  • 1Oncopharmacology Laboratory, Centre Antoine Lacassagne, Nice, France.

Clinical Pharmacology and Therapeutics
|April 1, 1996
PubMed
Summary

Tamoxifen concentrations and metabolite levels significantly increase with age in breast cancer patients. Age is a key factor influencing tamoxifen pharmacokinetics, impacting drug levels and potential toxicity.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prognostic Values of Pre- and Post-Therapeutic FDG-PET in Anal Canal Cancer: Analysis of a Prospective Study.

Clinical colorectal cancer·2025
Same author

The Italian version of the Majeed pelvic score: translation, cross-cultural adaptation and validation.

Musculoskeletal surgery·2024
Same author

The Musculoskeletal Tumor Society Scoring system is a valid subjective and objective tool to evaluate outcomes of surgical treatment of patients affected by upper and lower extremity tumors.

Musculoskeletal surgery·2024
Same author

Cross-cultural adaptation and validation of the Italian version of the Western Ontario Rotator Cuff (WORC) index.

Musculoskeletal surgery·2024
Same author

The systemic deletion of interleukin-1α reduces myocardial inflammation and attenuates ventricular remodeling in murine myocardial infarction.

Scientific reports·2023
Same author

Fewer cetuximab-related skin-toxicities in colorectal cancer patients treated with encorafenib: a Yin and Yang effect of ERK paradoxical activation.

Annals of oncology : official journal of the European Society for Medical Oncology·2022

Area of Science:

  • Pharmacology
  • Oncology
  • Clinical Pharmacy

Background:

  • Tamoxifen is a widely used endocrine therapy for breast cancer.
  • Understanding its pharmacokinetics is crucial for optimizing treatment efficacy and minimizing toxicity.
  • Factors like age, hepatic function, and concomitant therapies can influence drug levels.

Purpose of the Study:

  • To investigate tamoxifen pharmacokinetics in breast cancer patients.
  • To explore the relationship between tamoxifen pharmacokinetics and pharmacodynamics (toxicity and clinical response).
  • To assess the influence of hepatic dysfunction, age, treatment duration, and chemotherapy on tamoxifen pharmacokinetics.

Main Methods:

  • Study included 316 breast cancer patients (247 postmenopausal women), with a mean age of 58.

Related Experiment Videos

  • 117 patients received tamoxifen as single therapy; 292 received 30 mg daily.
  • Tamoxifen and its metabolites (N-desmethyltamoxifen, N-desdimethyltamoxifen, primary alcohol, 4-hydroxytamoxifen) were quantified using HPLC from 794 blood samples.

    • Main Results:

    • Significant interpatient variability in tamoxifen and metabolite serum concentrations was observed.
    • Tamoxifen and metabolite concentrations increased significantly with age.
    • Concomitant chemotherapy slightly increased tamoxifen levels; hepatic dysfunction had minimal impact.
    • Higher proportions of demethylated metabolites were associated with tamoxifen-related side effects.

    Conclusions:

    • Tamoxifen pharmacokinetics are significantly influenced by patient age, with concentrations increasing in older individuals.
    • Despite wide variability, age emerges as a critical factor in tamoxifen drug levels.
    • Further research may be needed to tailor tamoxifen dosing based on age and metabolic profiles.